Harold C. Simmons Cancer Center Population Science and Cancer Control Scientific Program Project Summary/Abstract A developing research program in the 2009 application, the Population Science and Cancer Control (PS) Scientific Program has grown substantially in peer-reviewed funding from less than $500,000 to $5.6 million in 2013. Of that amount, $2.5 million represents funding from the NCI, $1.5 million from other NIH divisions, and close to $1 million from the Agency for Healthcare Research and Quality (AHRQ). Total prevention and screening projects from the Cancer Prevention and Research Institute of Texas (CPRIT) currently totals $2.4 million. Intra-programmatic collaborations are strong, representing 44% of the Program's 2013 publications; 13% are inter-programmatic. Program members meet quarterly for updates and research presentations, with topic- focused bi-monthly works-in-progress sessions. Our large catchment area is the Dallas-Ft. Worth statistical metropolitan area, with a special focus on uninsured Dallas county residents cared for by the Parkland Health and Hospital System . Thus, the program has a heavy focus on cancer disparities and conducts research among large numbers of traditionally underserved individuals. To address the needs of this catchment area, the PS Program functions along the following themes: Theme 1: Cancer prevention research includes study of biomarkers and behaviors 1.a. Biomarkers for colon and hepatocellular cancers 1.b. Risk prevention behaviors Theme 2: Screening for early detection of colon, hepatocellular, and esophageal cancers 2.a. Population-based screening for colon cancer 2.b. Screening for hepatocellular cancer 2.c. Screening for esophageal cancer Theme 3: Survivorship (Developing) We have focused on programmatic grants allowing for discoveries across processes of care that can be translated into improved care in our catchments' health systems. Sixteen of 24 members have been recruited to Dallas since the arrival of Co-Leader Dr. Celette Sugg Skinner in 2007: six PhDs in the Department of Clinical Sciences with strong and diverse skills in mixed-methods, geo-spatial, biomedical, and multi-level research; a psychologist in the Department of Psychiatry; five MDs in the Department of Medicine with expertise in clinical epidemiology and health services research; and four PhDs in cancer-related health promotion and epidemiology in the UT School of Public Health's Dallas Campus.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA142543-10S3
Application #
10260732
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Belin, Precilla L
Project Start
2010-08-03
Project End
2021-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
10
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Li, Xiangyi; Baek, GuemHee; Ramanand, Susmita G et al. (2018) BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. Cell Rep 22:796-808
Li, Ran; Chiguru, Srinivas; Li, Li et al. (2018) Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer. Mol Cancer Ther 17:169-182
Balasubramanian, Bijal A; Jetelina, Katelyn K; Bowen, Michael et al. (2018) Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord 21:26-35
Rashdan, Sawsan; Minna, John D; Gerber, David E (2018) Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med 6:472-478
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
Hamann, Heidi A; Shen, Megan J; Thomas, Anna J et al. (2018) Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health 3:195-203
Miyata, Naoteru; Morris, Lindsey L; Chen, Qing et al. (2018) Microbial Sensing by Intestinal Myeloid Cells Controls Carcinogenesis and Epithelial Differentiation. Cell Rep 24:2342-2355
Mokdad, Ali A; Xie, Xian-Jin; Zhu, Hong et al. (2018) Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer 124:3339-3345
Murphy, Caitlin C; Singal, Amit G; Baron, John A et al. (2018) Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. Gastroenterology 155:1716-1719.e4
Barnes, Arti; Betts, Andrea C; Borton, Eric K et al. (2018) Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS 32:1861-1870

Showing the most recent 10 out of 501 publications